The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets
ASN Neuro · 2021-01 · 13 (1)
DOI: 10.1177/17590914211018100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ASN Neuro, online erschienen am 29.05.2021. Verfasst von Rongrong Bai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Neuroscience Center, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 304 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cerebrovascular diseases are pathological conditions involving impaired blood flow in the brain, primarily including ischaemic stroke, intracranial haemorrhage, and subarachnoid haemorrhage. The nucleotide-binding and oligomerisation (NOD) domain-like receptor (NLR) family pyrin domain (PYD)-containing 3 (NLRP3) inflammasome is a protein complex and a vital component of the immune system. Emerging evidence has indicated that the NLRP3 inflammasome plays an important role in cerebrovascular diseases. The function of the NLRP3 inflammasome in the pathogenesis of cerebrovascular diseases remains an interesting field of research. In this review, we first summarised the pathological mechanism of cerebrovascular diseases and the pathological mechanism of the NLRP3 inflammasome in aggravating atherosclerosis and cerebrovascular diseases. Second, we outlined signalling pathways through which the NLRP3 inflammasome participates in aggravating or mitigating cerebrovascular diseases. Reactive oxygen species (ROS)/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), ROS/thioredoxin-interacting protein (TXNIP) and purinergic receptor-7 (P2X7R) signalling pathways can activate the NLRP3 inflammasome; activation of the NLRP3 inflammasome can aggravate cerebrovascular diseases by mediating apoptosis and pyroptosis. Autophagy/mitochondrial autophagy, nuclear factor E2-related factor-2 (Nrf2), interferon (IFN)-β, sirtuin (SIRT), and phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) reportedly alleviate cerebrovascular diseases by inhibiting NLRP3 inflammasome activation. Finally, we explored specific inhibitors of the NLRP3 inflammasome based on the two-step activation of the NLRP3 inflammasome, which can be developed as new drugs to treat cerebrovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Neuroscience Center, The First Hospital of Jilin University, Changchun, China.
- Department of Hepatopancreatobiliary Surgery, The First Hospital of Jilin University, Changchun, China.
ORCID-Profile: Rongrong Bai
Zitieren
APA
Bai, R., Lang, Y., Shao, J., Deng, Y., Refuhati, R., & Cui, L. (2021). The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets. ASN Neuro, 13(1). https://doi.org/10.1177/17590914211018100
Vancouver
Bai R, Lang Y, Shao J, Deng Y, Refuhati R, Cui L. The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets. ASN Neuro. 2021;13(1). doi:10.1177/17590914211018100
BibTeX
@article{Bai2021,
author = {Bai, Rongrong and Lang, Yue and Shao, Jie and Deng, Yu and Refuhati, Reyisha and Cui, Li},
title = {The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets},
journal = {ASN Neuro},
year = {2021},
volume = {13},
number = {1},
doi = {10.1177/17590914211018100}
}
EUVIMED